247 related articles for article (PubMed ID: 32345668)
1. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Lehrer S; Rheinstein PH
Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2020 Oct; 43(10):685-689. PubMed ID: 32568785
[TBL] [Abstract][Full Text] [Related]
3. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
4. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.
Gao P; Ye L; Cheng H; Li H
Cell Mol Neurobiol; 2021 Oct; 41(7):1431-1440. PubMed ID: 32719966
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genomic features of SPOP-mutant prostate cancer.
Nakazawa M; Fang M; H Marshall C; Lotan TL; Isaacsson Velho P; Antonarakis ES
Prostate; 2022 Feb; 82(2):260-268. PubMed ID: 34783071
[TBL] [Abstract][Full Text] [Related]
6. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA
Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.
Ge K; Minhas F; Duhadaway J; Mao NC; Wilson D; Buccafusca R; Sakamuro D; Nelson P; Malkowicz SB; Tomaszewski J; Prendergast GC
Int J Cancer; 2000 Apr; 86(2):155-61. PubMed ID: 10738240
[TBL] [Abstract][Full Text] [Related]
9. BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
Kaur I; Behl T; Sundararajan G; Panneerselvam P; Vijayakumar AR; Senthilkumar GP; Venkatachalam T; Jaglan D; Yadav S; Anwer K; Fuloria NK; Sehgal A; Gulati M; Chigurupati S
Neurotox Res; 2023 Dec; 41(6):698-707. PubMed ID: 37847429
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
Shoag J; Liu D; Ma X; Oromendia C; Christos P; Ballman K; Angulo C; Cai PY; Gaffney C; Klein E; Karnes J; Den RB; Liu Y; Davicioni E; Barbieri CE
Urol Oncol; 2020 May; 38(5):418-422. PubMed ID: 32192889
[TBL] [Abstract][Full Text] [Related]
11. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
[TBL] [Abstract][Full Text] [Related]
13. Convergent lines of evidence support BIN1 as a risk gene of Alzheimer's disease.
Zhu J; Liu X; Yin H; Gao Y; Yu H
Hum Genomics; 2021 Jan; 15(1):9. PubMed ID: 33516273
[TBL] [Abstract][Full Text] [Related]
14. CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
Zhu Y; Wen J; Huang G; Mittlesteadt J; Wen X; Lu X
Prostate; 2021 Jan; 81(1):81-88. PubMed ID: 33022763
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals.
Tan MS; Yu JT; Jiang T; Zhu XC; Guan HS; Tan L
Neurobiol Aging; 2014 Jul; 35(7):1781.e1-8. PubMed ID: 24582639
[TBL] [Abstract][Full Text] [Related]
16. BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
Glennon EB; Whitehouse IJ; Miners JS; Kehoe PG; Love S; Kellett KA; Hooper NM
PLoS One; 2013; 8(10):e78806. PubMed ID: 24205320
[TBL] [Abstract][Full Text] [Related]
17. Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.
Greenbaum L; Ravona-Springer R; Lubitz I; Schmeidler J; Cooper I; Sano M; Silverman JM; Heymann A; Beeri MS
Eur Neuropsychopharmacol; 2016 Apr; 26(4):787-95. PubMed ID: 26947052
[TBL] [Abstract][Full Text] [Related]
18. TP53, SPOP and PIK3CA Genes Status in Prostate Cancer.
Al Zoubi MS; Otoum R; Alorjani MS; Al Bashir S; Al Trad B; Abualrja MI; Al-Khatib SM; Al-Batayneh K
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3365-3371. PubMed ID: 33247697
[TBL] [Abstract][Full Text] [Related]
19. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
[TBL] [Abstract][Full Text] [Related]
20. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]